• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Jobs cuts in Q1 and then job cuts later this year/early next year

anonymous

Guest
There is no such thing as a 1 time job cut. The company is losing patents and exclusivity on many of its drugs over the course of the next two years and they will be shedding people as time goes on. This is just the first of many to come.
 

<



There is no such thing as a 1 time job cut. The company is losing patents and exclusivity on many of its drugs over the course of the next two years and they will be shedding people as time goes on. This is just the first of many to come.

Hey dumb fuck, this company has had at least one layoff a year for the past four years. Tell us something we don't know.
 




Hey dumb fuck, this company has had at least one layoff a year for the past four years. Tell us something we don't know.

Not of this size. This one is huge. 6% of the work force is being laid off and if you count non-essential people who are counted (janitors etc) your talking about almost 10%.

1 out of every 10 you know at Allergan will be gone soon.